These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 38035090)
21. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions. Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712 [TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of sex bias differences in COVID-19 mortality. Li Y; Jerkic M; Slutsky AS; Zhang H Crit Care; 2020 Jul; 24(1):405. PubMed ID: 32646459 [TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 infection as a trigger of autoimmune response. Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235 [TBL] [Abstract][Full Text] [Related]
25. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197 [TBL] [Abstract][Full Text] [Related]
26. Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses. Spatola M; Nziza N; Jung W; Deng Y; Yuan D; Dinoto A; Bozzetti S; Chiodega V; Ferrari S; Lauffenburger DA; Mariotto S; Alter G Brain; 2023 Oct; 146(10):4292-4305. PubMed ID: 37161609 [TBL] [Abstract][Full Text] [Related]
27. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Bunders MJ; Altfeld M Immunity; 2020 Sep; 53(3):487-495. PubMed ID: 32853545 [TBL] [Abstract][Full Text] [Related]
28. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses. Gadi N; Wu SC; Spihlman AP; Moulton VR Front Immunol; 2020; 11():2147. PubMed ID: 32983176 [TBL] [Abstract][Full Text] [Related]
29. B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic - when immunosuppression meets infection? Mycko MP Neurol Neurochir Pol; 2020; 54(6):490-501. PubMed ID: 33073348 [TBL] [Abstract][Full Text] [Related]
30. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System. Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375 [TBL] [Abstract][Full Text] [Related]
31. Antibody tests for identification of current and past infection with SARS-CoV-2. Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ; Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900 [TBL] [Abstract][Full Text] [Related]
32. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751 [TBL] [Abstract][Full Text] [Related]
33. Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger? Pivonello R; Auriemma RS; Pivonello C; Isidori AM; Corona G; Colao A; Millar RP Neuroendocrinology; 2021; 111(11):1066-1085. PubMed ID: 33242856 [TBL] [Abstract][Full Text] [Related]
34. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent. Menéndez SG; Martín Giménez VM; Holick MF; Barrantes FJ; Manucha W Life Sci; 2022 May; 297():120464. PubMed ID: 35271880 [TBL] [Abstract][Full Text] [Related]
36. Myoclonus status revealing COVID 19 infection. Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232 [TBL] [Abstract][Full Text] [Related]